# FDA Inspection 1008217 - Bay-Shore Surgical, LLC - April 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/bay-shore-surgical-llc/70caac35-9743-45a8-9cfd-9c2afdf803c0
Source feed: FDA_Inspections

> FDA Inspection 1008217 for Bay-Shore Surgical, LLC on April 13, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008217
- Company Name: Bay-Shore Surgical, LLC
- Inspection Date: 2017-04-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 922385 - 2015-04-16](https://www.keypedia.com/records/fda_inspections/bay-shore-surgical-llc/aa65ed69-8d3f-4d9f-8e23-6073e5525188)
- [FDA Inspection 744579 - 2011-09-15](https://www.keypedia.com/records/fda_inspections/bay-shore-surgical-llc/783a7ffa-aa1a-4536-b5e6-4d78b79b54ec)
- [FDA Inspection 679397 - 2010-09-07](https://www.keypedia.com/records/fda_inspections/bay-shore-surgical-llc/8d26911c-cd45-46f0-a696-2178affcbea2)

Company: https://www.keypedia.com/companies/bay-shore-surgical-llc/149c65c3-cd91-4693-a612-4a4d8219b969

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d